Glenmark Pharma gets USFDA nod for progesterone inserts; eyes $59 million market

Glenmark gets USFDA nod for 100 mg progesterone vaginal inserts, a generic to Endometrin, to be sold in US, targeting fertility care, Endometrin sales were $59.2 million dollars

Leave a Reply

Your email address will not be published. Required fields are marked *